Truist Securities Maintains Hold on GoodRx Holdings, Lowers Price Target to $5.5
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Jailendra Singh has maintained a Hold rating on GoodRx Holdings (NASDAQ:GDRX) but has lowered the price target from $8 to $5.5.
November 10, 2023 | 2:42 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Truist Securities has maintained a Hold rating on GoodRx Holdings but reduced the price target from $8 to $5.5, indicating a potential downside or limited upside.
The reduction in price target by Truist Securities suggests that the analyst sees less potential for price appreciation in GoodRx Holdings' stock. This could lead to a negative sentiment among investors and potentially cause a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100